Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1
Restricted accessResearch articleFirst published online July, 2025
Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1
Elevated systolic blood pressure (SBP) and resting heart rate (RHR) contribute to pathogenesis of diabetic complications. They increase inflammation which can upregulate leucine-rich α-2-glycoprotein 1 (LRG1), an emerging biomarker of cognitive decline.
Objective
To examine association between double product (DP, derived from multiplying SBP and RHR) and cognitive function in type 2 diabetes (T2D), with possible mediation by plasma LRG1.
Methods
In this prospective cohort of 1319 patients (mean age 62.5 ± 7.3), plasma LRG1 was measured with enzyme-linked immunosorbent assay. Cognitive function was assessed using Repeatable Battery for Assessment of Neuropsychological Status (RBANS). Cross-lagged panel analysis was done to examine temporal relationship between DP and cognitive function.
Results
Baseline DP was associated with lower baseline RBANS total score (adjusted coefficient = −2.43; 95%CI −4.76, −0.10; p = 0.041). 586 patients were followed up to 8.6 years. Baseline DP was associated with follow-up RBANS total score (adjusted coefficient = −3.80; 95%CI −6.51, −1.10; p = 0.006). It was also associated with lower follow-up RBANS scores in immediate memory and delayed memory with adjusted coefficients −4.38 (95%CI −8.49, −0.28; p = 0.036) and −5.12 (95%CI −9.88, −0.35; p = 0.035) respectively. In cross-lagged panel analysis, standardized effect size of baseline DP on follow-up RBANS total score (β = −0.08; p = 0.002) was larger than that of baseline RBANS total score on follow-up DP (β = −0.04; p = 0.266). LRG1 accounted for 14.7% of the association in mediation analysis (p = 0.035).
Conclusions
DP was independently associated with cognitive function with possible mediation by LRG1. DP preceded decline in cognitive function. DP may be potential intervention and monitoring target for prevention of cognitive impairment and possibly Alzheimer's disease in T2D.
International Diabetes Federation. IDF diabetes atlas. 10th ed.Brussels, Belgium: International Diabetes Federation, 2021.
2.
American Diabetes Association Professional Practice Committee. 13. Older adults: standards of care in diabetes-2024. Diabetes Care2024; 47(Suppl 1): S244–S257.
KalyaniRRGoldenSHCefaluWT. Diabetes and aging: unique considerations and goals of care. Diabetes Care2017; 40: 440–443.
5.
ArnoldSEArvanitakisZMacauley-RambachSL, et al.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol2018; 14: 168–181.
6.
IkedaSShinoharaKEnzanN, et al.A higher resting heart rate is associated with cardiovascular event risk in patients with type 2 diabetes mellitus without known cardiovascular disease. Hypertens Res2023; 46: 1090–1099.
7.
Jandeleit-DahmKCooperME. Hypertension and diabetes. Curr Opin Nephrol Hypertens2002; 11: 221–228.
8.
ChenSChengW. Relationship between lipid profiles and hypertension: a cross-sectional study of 62,957 Chinese adult males. Front Public Health2022; 10: 895499.
9.
HuGBarengoNCTuomilehtoJ, et al.Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension2004; 43: 25–30.
10.
HillisGSHataJWoodwardM, et al.Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J Am Heart Assoc2012; 1: e002832.
11.
CustodisFSchirmerSHBaumhäkelM, et al.Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol2010; 56: 1973–1983.
12.
DharmashankarKWidlanskyME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep2010; 12: 448–455.
13.
SenaCMPereiraAMSeiçaR. Endothelial dysfunction – a major mediator of diabetic vascular disease. Biochim Biophys Acta2013; 1832: 2216–2231.
14.
GoldsteinFCLeveyAISteenlandNK. High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc2013; 61: 67–73.
15.
NovakVHajjarI. The relationship between blood pressure and cognitive function. Nat Rev Cardiol2010; 7: 686–698.
16.
ObisesanTOObisesanOAMartinsS, et al.High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the third national health and nutrition examination survey. J Am Geriatr Soc2008; 56: 501–509.
17.
RichmondRLawJKay-LambkinF. Higher blood pressure associated with higher cognition and functionality among centenarians in Australia. Am J Hypertens2011; 24: 299–303.
18.
KivipeltoMHelkalaELLaaksoMP, et al.Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br Med J2001; 322: 1447–1451.
19.
MaZQuYMaH, et al.Associations between resting heart rate and cognitive decline in Chinese oldest old individuals: a longitudinal cohort study. BMC Geriatr2024; 24: 14.
20.
BlomKEmmelot-VonkMHKoekHL. The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review. Maturitas2013; 76: 113–117.
21.
GiangLMTighiouartHLouKV, et al.Measures of blood pressure and cognition in dialysis patients. Hemodial Int2013; 17: 24–31.
22.
KloppenborgRPvan den BergEKappelleLJ, et al.Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol2008; 585: 97–108.
23.
WodMJensenMTGalatiusS, et al.Resting heart rate is not associated with cognitive function. Neuroepidemiology2018; 50: 160–167.
24.
AlipourHGoldustM. The association between blood pressure components and cognitive functions and cognitive reserve. Clin Exp Hypertens2016; 38: 95–99.
25.
FingerEC. Increased heart rate and energy expenditure in frontotemporal dementia. Brain2017; 140: 10–12.
26.
ReitzCLuchsingerJA. Relation of blood pressure to cognitive impairment and dementia. Curr Hypertens Rev2007; 3: 166–176.
27.
TzourioC. Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialog Clin Neurosci2007; 9: 61–70.
28.
NakagoshiNKuboSNishidaY, et al.Determinants of double product: a cross-sectional study of urban residents in Japan. Environ Health Prev Med2023; 28: 37.
29.
SobiczewskiWWirtweinMKowalczysE, et al.Heart rate and double product in relation to insulin resistance in patients with hypertension and coronary artery disease. Kardiol Pol2013; 71: 47–52.
30.
CamilliCHoehAEDe RossiG, et al.LRG1: an emerging player in disease pathogenesis. J Biomed sci2022; 29: 6.
31.
LowSMohAPandianB, et al.Association between plasma LRG1 and lower cognitive function in asians with type 2 diabetes mellitus. J Clin Endocrinol Metab2024; 109: e1732–e1740.
32.
LowSMohAGohKS, et al.Association between kidney disease index and decline in cognitive function with mediation by arterial stiffness in asians with type 2 diabetes. J Alzheimers Dis Rep2024; 8: 1199–1210.
33.
LowSNgTPLimCL, et al. Association between lower extremity skeletal muscle mass and impaired cognitive function in type 2 diabetes. Sci Rep2020; 10: 2956.
34.
NyuntMSFonesCNitiM, et al.Criterion-based validity and reliability of the geriatric depression screening scale (GDS-15) in a large validation sample of community-living Asian older adults. Aging Ment Health2009; 13: 376–382.
35.
LowSGohKSNgTP, et al.The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore. Clin Nutr2020; 39: 2274–2281.
36.
World Health Organization. Global physical activity questionnaire analysis guide. Geneva, Switzerland: World Health Organization, 2021.
37.
NationDAWierengaCEDelano-WoodL, et al.Elevated pulse pressure is associated with age-related decline in language ability. J Int Neuropsychol Soc2010; 16: 933–938.
38.
WaldsteinSRRiceSCThayerJF, et al.Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore longitudinal study of aging. Hypertension2008; 51: 99–104.
39.
LeveyASStevensLASchmidCH, et al.A new equation to estimate glomerular filtration rate. Ann Intern Med2009; 150: 604–612.
40.
RandolphCTierneyMCMohrE, et al.The repeatable battery for the assessment of neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol1998; 20: 310–319.
41.
CollinsonSLFangSHLimML, et al.Normative data for the repeatable battery for the assessment of neuropsychological status in elderly Chinese. Arch Clin Neuropsychol2014; 29: 442–455.
42.
ChenMMHuangXXuC, et al.High remnant cholesterol level potentiates the development of hypertension. Front Endocrinol2022; 13: 830347.
43.
AllisonPDWilliamsRMoral-BenitoE. Maximum likelihood for cross-lagged panel models with fixed effects. Socius2017; 3: 1–17.
44.
ZhangJJiaXLiY, et al.The longitudinal bidirectional association between sarcopenia and cognitive function in community-dwelling older adults: findings from the China health and retirement longitudinal study. J Glob Health2023; 13: 04182.
45.
BaronRMKennyDA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Person Soc Psychol1986; 51: 1173–1182.
BuieJJWatsonLSSmithCJ, et al.Obesity-related cognitive impairment: the role of endothelial dysfunction. Neurobiol Dis2019; 132: 104580.
48.
SaleemMHerrmannNDinoffA, et al.Association between endothelial function and cognitive performance in patients with coronary artery disease during cardiac rehabilitation. Psychosom Med2019; 81: 184–191.
49.
ParkWCSeoIKimSH, et al.Association between resting heart rate and inflammatory markers (white blood cell count and high-sensitivity c-reactive protein) in healthy Korean people. Korean J Fam Med2017; 38: 8–13.
50.
MaoMLiuRDongY, et al.Resting heart rate, cognitive function, and inflammation in older adults: a population-based study. Aging Clin Exp Res2023; 35: 2821–2829.
51.
KnierimJJ. The hippocampus. Curr Biol2015; 25: R1116–R1121.
52.
MiyajimaMNakajimaMMotoiY, et al.Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex. PLoS One2013; 8: e74453.
53.
AkibaCNakajimaMMiyajimaM, et al.Leucine-rich α2-glycoprotein overexpression in the brain contributes to memory impairment. Neurobiol Aging2017; 60: 11–19.
54.
XuZPYangSLZhaoS, et al.Biomarkers for early diagnostic of mild cognitive impairment in type-2 diabetes patients: a multicentre, retrospective, nested case-control study. EBioMedicine2016; 5: 105–113.
55.
JiaRXLiangJHXuY, et al.Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis. BMC Geriatr2019; 19: 181.
56.
KellyMEDuffHKellyS, et al.The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. System Rev2017; 6: 259.
57.
KeyMNSzabo-ReedAN. Impact of diet and exercise interventions on cognition and brain health in older adults: a narrative review. Nutrients2023; 15: 2495.
58.
KheirouriSAlizadehM. MIND Diet and cognitive performance in older adults: a systematic review. Crit Revi Food Sci Nutr2022; 62: 8059–8077.
59.
NuzumHStickelACoronaM, et al.Potential benefits of physical activity in MCI and dementia. Behav Neurol2020; 2020: 7807856.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
